Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization-Reference-Cited by-同舟云学术

Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization

Published:2011-09 Issue:40 Volume:29 Page:6994-7001
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Madhi Shabir A.,Violari Avy,Klugman Keith P.,Lin Gina,McIntyre James A.,von Gottberg Anne,Jean-Philippe Patrick,Cotton Mark F.,Adrian Peter

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. The potential indirect effect of conjugate pneumococcal vaccines;O’Brien;Vaccine,2003

2. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine;Mbelle;J Infect Dis,1999

3. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr Infect Dis J,2000

4. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine;Nurkka;Pediatr Infect Dis J,2001

5. Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants;Obaro;Pediatr Infect Dis J,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial;Vaccine: X;2021-04

2. Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine;Vaccine;2020-06

3. Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose;Clinical Infectious Diseases;2020-01-29

4. Pneumococcal whole-cell and protein-based vaccines: changing the paradigm;Expert Review of Vaccines;2017-11-12

5. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage;Vaccine;2017-08